Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Orchestra BioMed Holdings (OBIO) Interest & Investment Income: 2023-2025

Historic Interest & Investment Income for Orchestra BioMed Holdings (OBIO) over the last 2 years, with Sep 2025 value amounting to -$515,000.

  • Orchestra BioMed Holdings' Interest & Investment Income fell 156.22% to -$515,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $137,000, marking a year-over-year decrease of 96.52%. This contributed to the annual value of $3.4 million for FY2024, which is 12.81% down from last year.
  • Latest data reveals that Orchestra BioMed Holdings reported Interest & Investment Income of -$515,000 as of Q3 2025, which was down 1,330.56% from -$36,000 recorded in Q2 2025.
  • Orchestra BioMed Holdings' Interest & Investment Income's 5-year high stood at $1.1 million during Q4 2023, with a 5-year trough of -$515,000 in Q3 2025.
  • In the last 3 years, Orchestra BioMed Holdings' Interest & Investment Income had a median value of $902,000 in 2024 and averaged $554,889.
  • As far as peak fluctuations go, Orchestra BioMed Holdings' Interest & Investment Income grew by 0.11% in 2024, and later tumbled by 156.22% in 2025.
  • Over the past 3 years, Orchestra BioMed Holdings' Interest & Investment Income (Quarterly) stood at $1.1 million in 2023, then plummeted by 52.89% to $522,000 in 2024, then plummeted by 156.22% to -$515,000 in 2025.
  • Its last three reported values are -$515,000 in Q3 2025, -$36,000 for Q2 2025, and $166,000 during Q1 2025.